BEAMSTART Logo

HomeNews

INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients

GlobeNewswire LogoGlobeNewswire23h ago

INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients - GlobeNewswire

Quick Summary:

For example, the Company is using forward-looking statements when it discusses the collaboration with Israel’s largest healthcare provider, the planned evaluation of the INSPIRA ART100 system in organ transplant procedures, the potential of the Company's technology to address critical needs in advanced pulmonary care, that the clinical data collected during the procedures will be used to support the ongoing development program of the INSPIRA ART500 system, and the expected benefits and uses of its products.

RA'ANANA, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N.Ltd.(NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that the INSPIRA™ ART100 has been approved by Israel's largest healthcare provider to undergo a clinical validation by leading physicians who intend to use the innovative life-support and diagnostic device during organ transplant procedures. As part of this advancement, Inspira will deploy the U.S.

The system's proprietary hardware and software platform serves as the foundation for the Company's flagship INSPIRA ART500 system, which is currently under development and aims to revolutionize respiratory care by providing direct blood oxygenation without mechanical ventilation.

or

Article Details

Author / Journalist: Inspira Technologies

Category: Technology

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Negative

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-05-07 @ 12:45:00 (23 hours ago)

News Timezone: GMT +8:00

News Source URL: globenewswire.com

Language: English

Article Length: 786 words

Reading Time: 5 minutes read

Sentences: 23 lines

Sentence Length: 35 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © GlobeNewswire

News ID: 28468556

View Article Analysis

About GlobeNewswire

Main Topics: Technology

Official Website: globenewswire.com

Update Frequency: 97 posts per day

Year Established: 1998

Headquarters: China

News Last Updated: 8 hours ago

Coverage Areas: China

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #116

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients" has 786 words across 23 sentences, which will take approximately 4 - 7 minutes for the average person to read.

Which news outlet covered this story?

The story "INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients" was covered 23 hours ago by GlobeNewswire, a news publisher based in China.

How trustworthy is 'GlobeNewswire' news outlet?

GlobeNewswire is a fully independent (privately-owned) news outlet established in 1998 that covers mostly technology news.

The outlet is headquartered in China and publishes an average of 97 news stories per day.

It's most recent story was published 8 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Negative, indicating that people regard this as "bad news".

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #28468556
  • URL: https://chronographically.beamstart.com/news/inspira-art100-system-approved-by-17466222196846

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.